Tahir Amin is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK). He has also served as advisor/consultant to international groups including the European Patent Office, the World Health Organization, and Unitaid, and has testified before the US Congress on patents and unsustainable drug prices.
